Literature DB >> 15459307

Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?

Jean Klastersky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459307     DOI: 10.1056/NEJMe048203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2006-09-12       Impact factor: 3.603

2.  Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors:  Johan Maertens; Griet Huysmans; Koen Theunissen
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

3.  Invasive fungal infections in acute leukemia.

Authors:  Vijaya R Bhatt; George M Viola; Alessandra Ferrajoli
Journal:  Ther Adv Hematol       Date:  2011-08

4.  The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.

Authors:  Yoshikazu Ito; Kazuma Ohyashiki; Isao Yoshida; Makoto Takeuchi; Yasutaka Aoyama; Atsuko Mugitani; Yasuhiro Matsuura; Hisashi Wakita; Mitsuhiro Matsuda; Erina Sakamoto; Toru Kiguchi; Akio Urabe; Kazuo Tamura; Akihisa Kanamaru; Toru Masaoka
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

5.  Risk-adapted strategy for the management of febrile neutropenia in cancer patients.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2007-02-09       Impact factor: 3.603

6.  Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies.

Authors:  Lorenz Grigull; Andreas Beilken; Hansjoerg Schmid; P Kirschner; Karl-Walter Sykora; Christin Linderkamp; Frank Donnerstag; Lilia Goudeva; Hans-Gert Heuft; Karl Welte
Journal:  Support Care Cancer       Date:  2006-02-16       Impact factor: 3.603

Review 7.  Current and future therapeutic options in the management of invasive aspergillosis.

Authors:  Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Investigator initiated trials (IITs).

Authors:  Viraj Suvarna
Journal:  Perspect Clin Res       Date:  2012-10

9.  Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea.

Authors:  Jin Seok Kim; June-Won Cheong; Ho Jin Shin; Jong Wook Lee; Je-Hwan Lee; Deok-Hwan Yang; Won Sik Lee; Hawk Kim; Joon Seong Park; Sung-Hyun Kim; Yang Soo Kim; Jae-Yong Kwak; Yee Soo Chae; Jinny Park; Young Rok Do; Yoo Hong Min
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

10.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.